These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10484534)

  • 21. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association of lipoprotein (a) with ischemic stroke and stenotic carotid atherosclerosis].
    Tmoyan NA; Ezhov MV; Afanasieva OI; Klesareva EA; Afanasieva MI; Balakhonova TV; Pokrovsky SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):42-48. PubMed ID: 32307429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis.
    Bailleul S; Couderc R; Rossignol C; Fermanian J; Boutouchent F; Farnier MA; Etienne J
    Clin Chem; 1995 Feb; 41(2):241-5. PubMed ID: 7874778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.
    Kronenberg F; König P; Lhotta K; Ofner D; Sandholzer C; Margreiter R; Dosch E; Utermann G; Dieplinger H
    Arterioscler Thromb; 1994 Sep; 14(9):1399-404. PubMed ID: 8068599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
    Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men].
    Ezhov MV; Afanas'eva OI; Benevolenskaia GF; Savchenko AP; Balakhonova TV; Liakishev AA; Pokrovskiĭ SN
    Ter Arkh; 2000; 72(1):28-32. PubMed ID: 10687202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentration.
    Bigot E; Robert B; Bard JM; Mainard F
    Clin Chim Acta; 1997 Sep; 265(1):99-111. PubMed ID: 9352133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.
    Rifai N; Ma J; Sacks FM; Ridker PM; Hernandez WJ; Stampfer MJ; Marcovina SM
    Clin Chem; 2004 Aug; 50(8):1364-71. PubMed ID: 15155542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Egger G; Poewe W; Oberhollenzer F
    Circulation; 1997 Nov; 96(10):3300-7. PubMed ID: 9396420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
    J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.
    Sechi LA; De Marchi S
    J Investig Med; 2001 Jan; 49(1):12-20. PubMed ID: 11217142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.
    Xiong ZW; Wahlqvist ML; Ibiebele TI; Biegler BM; Balazs ND; Xiong DW; Lim YL
    Clin Biochem; 2004 Apr; 37(4):305-11. PubMed ID: 15003733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study.
    Bonora E; Kiechl S; Willeit J; Oberhollenzer F; Egger G; Bonadonna R; Muggeo M
    Diabetes Care; 1999 Aug; 22(8):1339-46. PubMed ID: 10480780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Associazione Medica Sabin.
    Zuliani G; Bader G; Imbastaro T; Mezzetti A; Taddeo U; Kostner GM; Fellin R
    Aging (Milano); 1995 Oct; 7(5):385-91. PubMed ID: 8719606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein(a) in renal disease.
    Kronenberg F; Utermann G; Dieplinger H
    Am J Kidney Dis; 1996 Jan; 27(1):1-25. PubMed ID: 8546123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein(a) as a determinant of the severity of angiographically defined carotid atherosclerosis.
    Watts GF; Mazurkiewicz JC; Tonge K; Nelson V; Warburton FG; Slavin BM
    QJM; 1995 May; 88(5):321-6. PubMed ID: 7796086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.